On May 5, 2020, the journal Cell Reports published an article on identifying tumor signatures to decide on appropriate targeted treatments. Researchers in a collaborative effort between the Francis Crick Institute, Roche Tissue Diagnostics, and the Royal Marsden Hospital, has devised a new way of studying a tumor in its entirety.